Department of Obstetrics and Gynecology, Sichuan University West China Second University Hospital, Chengdu, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University West China Second University Hospital, Chengdu, Sichuan, China.
Int J Gynecol Cancer. 2024 Nov 4;34(11):1704-1710. doi: 10.1136/ijgc-2024-005639.
To determine the relationship between the Silva pattern-based classification system and endocervical adenocarcinoma.
The PubMed, Embase, Central Cochrane Library, and Web of Science databases were systematically searched for studies that investigated the correlation between the Silva classification system and the oncology prognosis or pathological features of endocervical adenocarcinoma, published in the period from January 2013 to March 2024.
A total of 19 eligible studies including 3122 cases were included in this systematic review and meta-analysis. The combined death rate in the Silva A, Silva B, and Silva C patterns was 0% (95% CI 0.0% to 0.4%), 2.6% (95% CI 0.4% to 5.9%), and 14.0% (95% CI 9.4% to 19.2%), respectively; the combined recurrence rate in the Silva A, Silva B, and Silva C patterns was 0.1% (95% CI 0.0% to 1.2%), 5.1% (95% CI 1.6% to 10.0%), and 19.4% (95% CI 14.7% to 24.4%), respectively; the combined lymphovascular invasion rate in the Silva A, Silva B, and Silva C patterns was 0% (95% CI 0.0% to 0.5%), 21.0% (95% CI 16.9% to 25.4%), and 58.8% (95% CI 50.1% to 67.3%), respectively; and the combined International Federation of Gynecology and Obstetrics (FIGO) I rate in the Silva A, Silva B, and Silva C patterns was 99.3% (95% CI 97.6% to 100%), 93.7% (95% CI 86.4% to 98.7%), and 82.4% (95% CI 74.9% to 88.9%), respectively.
Our study found that Silva A was negatively correlated with death rate, while Silva C was positively correlated. There was no correlation regarding the death rate for Silva B. Based on these findings, it is suggested that the Silva pattern-based classification system can predict the prognosis of human papillomavirus (HPV)-related endocervical adenocarcinoma and assist in guiding patient treatment.
确定席尔瓦分类系统与宫颈内膜腺癌之间的关系。
系统检索了 2013 年 1 月至 2024 年 3 月期间发表的关于席尔瓦分类系统与宫颈内膜腺癌的肿瘤预后或病理特征相关性的研究,包括 PubMed、Embase、Cochrane 中心数据库和 Web of Science 数据库。
本系统评价和荟萃分析共纳入 19 项符合条件的研究,共计 3122 例。席尔瓦 A、B、C 型的总死亡率分别为 0%(95%CI0.0%至 0.4%)、2.6%(95%CI0.4%至 5.9%)和 14.0%(95%CI9.4%至 19.2%);席尔瓦 A、B、C 型的总复发率分别为 0.1%(95%CI0.0%至 1.2%)、5.1%(95%CI1.6%至 10.0%)和 19.4%(95%CI14.7%至 24.4%);席尔瓦 A、B、C 型的总淋巴管浸润率分别为 0%(95%CI0.0%至 0.5%)、21.0%(95%CI16.9%至 25.4%)和 58.8%(95%CI50.1%至 67.3%);席尔瓦 A、B、C 型的国际妇产科联合会(FIGO)I 期率分别为 99.3%(95%CI97.6%至 100%)、93.7%(95%CI86.4%至 98.7%)和 82.4%(95%CI74.9%至 88.9%)。
本研究发现,席尔瓦 A 与死亡率呈负相关,而席尔瓦 C 与死亡率呈正相关。席尔瓦 B 与死亡率无相关性。基于这些发现,建议席尔瓦分类系统可预测人乳头瘤病毒(HPV)相关宫颈内膜腺癌的预后,并有助于指导患者治疗。